Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe

Author:

Papatheodoridis G. V.1ORCID,Hatzakis A.1,Cholongitas E.1ORCID,Baptista-Leite R.23,Baskozos I.4,Chhatwal J.5ORCID,Colombo M.6,Cortez-Pinto H.78,Craxi A.9,Goldberg D.10,Gore C.11,Kautz A.12,Lazarus J. V.1314ORCID,Mendão L.1516,Peck-Radosavljevic M.17,Razavi H.18,Schatz E.19,Tözün N.20,van Damme P.2122,Wedemeyer H.23,Yazdanpanah Y.24,Zuure F.2526,Manns M. P.23

Affiliation:

1. Medical School of National; Kapodistrian University of Athens; Athens Greece

2. Institute of Health Sciences; Católica University of Portugal; Lisbon Portugal

3. Faculty of Health, Medicine and Life Sciences; Maastricht University; Maastricht The Netherlands

4. Ministry of Health; Athens Greece

5. Massachusetts General Hospital’ s; Institute for Technology Assessment and Harvard Medical School; Boston MA USA

6. Clinical and Research Center Humanitas; Rozzano Italy

7. European Association for the Study of the Liver; Geneva Switzerland

8. Faculdade de Medicina; Universidade de Lisbon; Lisbon Portugal

9. University of Palermo; Palermo Italy

10. School of Health and Life Sciences; Glasgow Caledonian University; Glasgow Scotland, UK

11. Hepatitis C Trust; World Hepatitis Alliance; London UK

12. Leberhilfe Projekt gUG; Cologne Germany

13. Barcelonai Institute for Global Health (ISGlobal); Hospital Clínic; University of Barcelona; Barcelona Spain

14. CHIP, Rigshospitalet; University of Copenhagen; Copenhagen Denmark

15. Portuguese Activist Group for HIV/AIDS Treatment; Lisbon Portugal

16. European AIDS Treatment Group; Brussels Belgium

17. Department of Internal Medicine and Gastroenterology; Klagenfurt Austria

18. Center for Disease Analysis; Lafayette CO USA

19. Correlation Network; Amsterdam The Netherlands

20. Acibadem Mehmet Ali Aydinlar University; Istanbul Turkey

21. Antwerp University; Antwerp Belgium

22. Viral Hepatitis Prevention Board; Antwerp Belgium

23. Hannover Medical School; Hannover Germany

24. INSERM; Université Paris Diderot; Paris France

25. Department of Infectious Diseases Research and Prevention; Public Health Service of Amsterdam; Amsterdam The Netherlands

26. Department of Internal Medicine; Amsterdam Infection and Immunity Institute (AI&II); Academic Medical Center; University of Amsterdam; Amsterdam The Netherlands

Funder

Gilead Sciences

AbbVie

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Reference59 articles.

1. Manns MP Presentation at EU HCV Policy Summit 2016

2. Hantzakis A Presentation at EU HCV Policy Summit 2016

3. Schatz E Presentation at EU HCV Policy Summit 2016

4. Busoi C Presentation at EU HCV Policy Summit 2016

5. Cortez-Pinto H Presentation at EU HCV Policy Summit 2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3